Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- University of Cambridge
- University of Birmingham
- Cranfield University
- University of East Anglia
- University of East Anglia;
- King's College London
- University of Nottingham
- ; University of Surrey
- The University of Manchester
- University of Birmingham;
- ;
- AALTO UNIVERSITY
- The University of Manchester;
- University of Cambridge;
- University of Leeds
- University of Newcastle
- ; King's College London
- ; University of Plymouth
- ; University of Southampton
- Durham University;
- King's College London;
- Loughborough University
- Loughborough University;
- Newcastle University;
- Swansea University
- The University of Edinburgh
- University of Bristol
- University of Derby
- University of Exeter
- University of Exeter;
- University of Manchester
- University of Nottingham;
- University of Plymouth
- University of Salford;
- University of Sheffield
- University of Sheffield;
- University of Surrey
- University of Sussex;
- University of Warwick
- 29 more »
- « less
-
Field
-
this challenge. Pathogens invade plant cells and hijack proteins that control protein synthesis, bending these processes to support pathogen growth. This project aims to target the protein-protein interactions
-
that underpin immune recognition by these proteins, and how they could be engineered to expand or otherwise improve their use in agriculture. Our target for developing new disease resistance is the most
-
the PhD student to propose targets to preserve liver metabolic health and prevent disease progression associated to poor dietary habits, which will be investigated in this project. This collaborative
-
interventions. These insights may ultimately lead to the identification of new targets for the development of therapies for ageing and age-related disease. For more information please contact: rebecca.c.taylor
-
, alongside complex drug screening, efficacy and clinical phenotype information. Using these datasets, you will undertake comprehensive strategies aimed at the characterisation and therapeutic targeting
-
range of reactivity, and particularly C-C bond formation. Directed evolution approaches will then be applied to guide the selectivity of the new enzymes towards target molecules and drug fragments
-
adaptations to different exercise stimuli, targeting both maximal and rapid force production. Outcomes will inform rehabilitation practices at the Defence Medical Rehabilitation Centre (DMRC) and across UK
-
communities are correlated with take-all severity Using these insights, you will target key microbial players for isolation and perform microbiome swaps to interrogate what an ‘optimal’ community of bacteria
-
. Modern systems research targets the ubiquitous need for efficient ML. ML research, conversely, is directly affected by how methods will be deployed. Furthermore, systems research increasingly explores ML
-
limited. No immunotherapy for meningiomas has yet gained FDA approval, though early-phase trials targeting IFN-alpha and PD-1 have been conducted. Emerging evidence highlights the crucial role of the immune